StreetAlpha
HCA Healthcare, Inc. · SEC Form 4

HCA Insider Trading

From SEC Form 416 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of HCA Healthcare, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $47.5M sold.

← HCA stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$47.5M8 sales · 8 insiders
Net−$47.5Mbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJan2026-02: sold $29.3MFebMarAprMayJunJulAugSepOct2026-11: sold $18.3MNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when HCA insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an HCA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every HCA insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 10, 2026Erica RossittoSVP & Chief Nurse ExecutiveSale3,500$505.81$1.8M13,426Nov 10Form 4
Nov 6, 2026Jon M FosterEVP and COOSale31,713$500.98$15.9M10,000Nov 6Form 4
Nov 4, 2026Michael J SchlosserEVP and Chief Clinical OfficerSale1,200$494.65$594K1,443Nov 6Form 4
Feb 18, 2026Michael R McAleveyEVP & Chief Legal & Admin Off.Sale1,694$533.37$904K8,853Feb 18Form 4
Feb 11, 2026Jennifer BerresSVP & Chief Human Res. OfficerSale8,020$514.58$4.1M11,993Feb 12Form 4
Feb 11, 2026Christopher F. WyattSVP & ControllerSale4,000$505.00$2M44,379Feb 12Form 4
Feb 3, 2026Michael S. CuffeEVP and Chief Clinical OfficerSale1,500$498.09$747K30,003Feb 5Form 4
Feb 3, 2026Samuel N HazenCEOSale42,877$501.04$21.5M32,276Feb 5Form 4
Nov 5, 2025Michael R McAleveyEVP & Chief Legal & Admin Off.Sale3,892$473.79$1.8M3,487Nov 5Form 4
Sep 8, 2025Michael S. CuffeEVP and Chief Clinical OfficerSale plan3,836$418.84$1.6M31,503Sep 8Form 4
May 13, 2025Jon M FosterEVP and COOSale15,698$369.32$5.8M12,646May 15Form 4
Mar 19, 2025Bank Of America Corp /de/10% ownerBuy25$25.18$6300Mar 28Form 4
Feb 14, 2025Jennifer BerresSVP & Chief Human Res. OfficerSale9,533$322.59$3.1M15,412Feb 18Form 4
Nov 14, 2024Kathleen M WhalenSVP & Chief Ethics OfficerSale1,474$357.99$528K9,454Nov 18Form 4
Nov 14, 2024Erol R AkdamarGroup PresidentSale2,900$353.00$1M6,843Nov 14Form 4
🔒 1 more trades. Create a free account or sign in to see them all.

HCA insider trading FAQ

Are HCA insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of HCA on the open market in 0 trades, and 8 sold $47.5M in 8 trades.

When did an HCA insider last buy shares?

Bank Of America Corp /de/ (10% owner) bought 25 shares for $630 on Mar 19, 2025, reported on Mar 28, 2025.

When did an HCA insider last sell shares?

Erica Rossitto (SVP & Chief Nurse Executive) sold 3,500 shares for $1.8M on Nov 10, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice